India, China emerge as world's preferred outsourcing partners in R&D
The rise of India and China as global
economies presents immense opportunities for the international
pharmaceutical industry. Besieged by ever-increasing
cost pressures, shorter product life cycles and numerous
regulatory challenges in the west, the industry is increasingly
shifting its R&D base to these two developing nations.
This is being done primarily to minimise the expenses,
time and risk involved in R&D.
December 22, 2005